The effect of anti-neoplastic drugs on murine acquired immunodeficiency syndrome.

The murine acquired immunodeficiency syndrome (MAIDS) is associated with proliferation of target cells that have been infected by a defective retrovirus. To control the growth of this primary neoplasia, virus-inoculated mice were treated with anti-neoplastic drugs. Paradoxically, cyclophosphamide, which is also immunosuppressive, was very effective in preventing the appearance and progression of the disease, in restoring a normal T cell function, and in depleting the number of infected target cells. This result suggests that the proliferating infected target cells were responsible for the immunodeficiency.

[1]  J. Mullins,et al.  Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14 , 1990, Nature.

[2]  P. Jolicoeur,et al.  Immunodeficiency and clonal growth of target cells induced by helper-free defective retrovirus. , 1989, Science.

[3]  H. Morse,et al.  Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P. Jolicoeur,et al.  Severe immunodeficiency disease induced by a defective murine leukaemia virus , 1989, Nature.

[5]  H. Morse,et al.  Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains , 1989, Journal of virology.

[6]  S. Klinken,et al.  Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS. , 1988, Journal of immunology.

[7]  A. Fauci,et al.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. , 1988, Science.

[8]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[9]  R. Buller,et al.  Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses , 1987, Journal of virology.

[10]  D. Mosier Animal models for retrovirus-induced immunodeficiency disease. , 1986, Immunological investigations.

[11]  R. Gallo,et al.  Human T-lymphotropic retroviruses , 1985, Nature.

[12]  H. Morse,et al.  Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice , 1985, The Journal of experimental medicine.

[13]  M. Haas,et al.  Immunopathology of B-cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV). , 1982, The American journal of pathology.

[14]  R. Daculsi,et al.  Characteristics of the cell populations involved in extra-thymic lymphosarcoma induced in C57BL/6 mice by RadLV-Rs. , 1981, Leukemia research.

[15]  F. Schabel,et al.  Comparative chemotherapy of AKR lymphoma and human hematological neoplasia. , 1974, Cancer research.

[16]  J. Turk,et al.  Selective depletion of lymphoid tissue by cyclophosphamide. , 1972, Clinical and experimental immunology.

[17]  J. Duplan,et al.  [Leukemogenic activity of the mouse radioleukosis virus]. , 1970, Bulletin du cancer.